Brigham Hyde Founder of Atropos Health Backed byBoston Millennia PartnersBreyer CapitalDana CallowJim Breyer LinkedIn SourcesMcKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI — 2024-05 Browse all founders · Browse investors
